Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Lalla
    Junior Member
    • Apr 2015
    • 7

    #1

    FPKM interpretation

    Hi all!

    I am analyzing differential isoform expression between some samples. I run Cuffdiff2 and i found the differentially expressed isoforms. I also calculated the porportion of the expression of each isoform compared to the expression of the gene (the sum of the expressions of all the isoforms of that gene). Now I need to better filter my results. I was thinking to focus on the highly expressed isoforms and on those with a relevant proportion, but I couldn't find a criteria to choose a cutoff based on the FPKM. When can I say that a gene or isoform is highly expressed? And how can I understand when a proportion is relevant? I would think that the relevance of the proportion depends also on the total expression, i.e an isoform which account for the 30% of an highly expressed gene might be not as relevant as an isoform which account for the 30% of a low expressed gene, am i correct?
    I had a look to related posts in this forum and to several articles but i couldn't find a clear guidline. Maybe the answer is not simple but if you could suggest me some statistical approach to analyze these data would be great.
    Thanks in advance!
  • Lalla
    Junior Member
    • Apr 2015
    • 7

    #2
    FPKM interpretation

    Hi all!

    I am analyzing differential isoform expression between some samples. I run Cuffdiff2 and i found the differentially expressed isoforms. I also calculated the porportion of the expression of each isoform compared to the expression of the gene (the sum of the expressions of all the isoforms of that gene). Now I need to better filter my results. I was thinking to focus on the highly expressed isoforms and on those with a relevant proportion, but I couldn't find a criteria to choose a cutoff based on the FPKM. When can I say that a gene or isoform is highly expressed? And how can I understand when a proportion is relevant? I would think that the relevance of the proportion depends also on the total expression, i.e an isoform which account for the 30% of an highly expressed gene might be not as relevant as an isoform which account for the 30% of a low expressed gene, am i correct?
    I had a look to related posts in this forum and to several articles but i couldn't find a clear guidline. Maybe the answer is not simple but if you could suggest me some statistical approach to analyze these data would be great.
    Thanks in advance!

    Comment

    • bastianwur
      Member
      • Feb 2014
      • 98

      #3
      There's no good answer for this.
      Besides that I'd use the p/q value from the output, that's at least easy .

      Comment

      • Lalla
        Junior Member
        • Apr 2015
        • 7

        #4
        Thanks for your reply.
        Is not possible at all to do some sort of normalization per abundance in FPKM? If FPKM reflect the expression of transcripts in my sample I think there should be a way to find out the "significance" of a change in relative abundance of a transcript per total expression of a gene. Any suggestion is warmly welcomed!

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
          by SEQadmin2



          Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

          Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
          ...
          10-14-2026, 09:55 AM
        • SEQadmin2
          New Genomics Technologies Take Aim at Long-Standing Limits
          by SEQadmin2


          Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

          We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
          ...
          09-28-2026, 10:25 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, Yesterday, 11:13 AM
        0 responses
        17 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, Yesterday, 10:48 AM
        0 responses
        18 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-15-2026, 10:52 AM
        0 responses
        36 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-14-2026, 05:39 AM
        0 responses
        42 views
        0 reactions
        Last Post SEQadmin2  
        Working...